|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.380 SEK | -3.12% |
|
-5.31% | -37.93% |
| 07-07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 07-01 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
Company Valuation: Vivesto AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,176 | 233.5 | 219.3 | 156 | 72.64 | 92.78 | - | - |
| Change | - | -80.14% | -6.11% | -28.83% | -53.45% | 27.73% | - | - |
| Enterprise Value (EV) 1 | 1,176 | 91 | 219.3 | 123.7 | 70.54 | 84.78 | 82.78 | 69.78 |
| Change | - | -92.26% | 140.94% | -43.56% | -43% | 20.19% | -2.36% | -15.7% |
| P/E | -8.74x | -1.28x | -1.7x | -4.14x | -2.25x | -2.74x | -2x | -1.48x |
| PBR | 2.13x | 0.45x | - | 0.99x | 0.58x | 0.65x | 0.64x | 0.59x |
| PEG | - | -0.1x | 0.1x | 0.1x | 0.2x | 0.1x | -0.1x | -0x |
| Capitalization / Revenue | 44.9x | 230x | - | - | - | - | - | - |
| EV / Revenue | 44.9x | 89.7x | - | - | - | - | - | - |
| EV / EBITDA | -11.8x | -1.01x | - | -3.34x | -2.16x | -2.83x | -1.84x | -1.13x |
| EV / EBIT | -9.14x | -0.55x | - | -2.95x | -2.05x | -2.73x | -1.8x | -1.11x |
| EV / FCF | -43.7x | -0.72x | - | -32.2x | -2.08x | -2.83x | -1.8x | -1.13x |
| FCF Yield | -2.29% | -138% | - | -3.11% | -48.1% | -35.4% | -55.6% | -88.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -30 | -34 | -24 | -7 | -6 | -3.06 | -4.19 | -5.65 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 26.19 | 1.015 | - | - | - | - | - | - |
| EBITDA 1 | -99.77 | -90.53 | - | -37.05 | -32.58 | -30 | -45 | -62 |
| EBIT 1 | -128.6 | -165 | - | -41.96 | -34.38 | -31 | -46 | -63 |
| Net income 1 | -132.7 | -166.7 | -128.7 | -39.75 | -0.006 | -31 | -46 | -63 |
| Net Debt 1 | - | -142.5 | - | -32.29 | -2.098 | -8 | -10 | -23 |
| Reference price 2 | 262.300 | 43.400 | 40.750 | 29.000 | 13.500 | 8.380 | 8.380 | 8.380 |
| Nbr of stocks (in thousands) | 4,484 | 5,380 | 5,380 | 5,380 | 5,380 | 11,071 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 4/23/24 | 2/20/25 | 3/1/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.74x | - | -2.83x | - | 9.73M | |
| 34.12x | 12.19x | 25.61x | 0.59% | 1,024B | |
| 27.48x | 6.29x | 17.41x | 2.1% | 618B | |
| 32.84x | 7.42x | 15.35x | 2.76% | 443B | |
| 19.59x | 4.68x | 11.59x | 2.83% | 349B | |
| 22.21x | 5.74x | 14.32x | 2.8% | 297B | |
| 21.76x | 4.48x | 12.7x | 1.96% | 264B | |
| 13.48x | 5.04x | 10.4x | 3.7% | 209B | |
| 25.29x | 6.61x | 11.66x | 2.62% | 208B | |
| -46.92x | 5.63x | 31.08x | 2.53% | 162B | |
| Average | 14.71x | 6.45x | 14.73x | 2.43% | 357.38B | |
| Weighted average by Cap. | 24.11x | 7.70x | 18.21x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VIVE Stock
- Valuation Vivesto AB
Select your edition
All financial news and data tailored to specific country editions
